AmPharma BV Pharmaceuticals Healthcare Deals and Alliances Profile Updated...
SummaryAMPharma BV AMPharma is a biopharmaceutical company that undertakes the preclinical and clinical development of recombinant human alkaline phosphatase therapeutics for the treatment of...
View ArticleRedHill Biopharma Announces First Patient Dosed In The OpenLabel Extension...
Life Sciences Jobs ...
View ArticleRedHill Biopharma Ltd. RedHill Biopharma Announces First Patient Dosed in the...
A first randomized doubleblind placebocontrolled Phase III clinical study with RHB104 for the treatment of Crohn's disease the MAP US study is ongoing in the U.S. and additional countries...
View ArticleRedHill Biopharma Announces First Patient Dosed in the OpenLabel Extension...
A first randomized doubleblind placebocontrolled Phase III clinical study with RHB104 for the treatment of Crohns disease the MAP US study is ongoing in the U.S. and additional countriesThe openlabel...
View ArticleTiGenix NV TIG Financial and Strategic SWOT Analysis Review Updated 13012017...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleURAC is Proud to Announce Pharmaceutical Specialties Inc. Has Earned URAC...
WASHINGTON March 21 2017 PRNewswire URAC the independent leader in promoting healthcare quality through accreditation certification and measurement is proud to announce that Pharmaceutical Specialties...
View ArticleQu Biologics Discovers That Immune Biomarkers May Predict Response to Novel...
VANCOUVER British Columbia March 22 2017 GLOBE NEWSWIRE Qu Biologics Inc. a biopharmaceutical company developing Site Specific Immunomodulators SSIs a unique platform of immunotherapies designed to...
View ArticleBiologic treatments for inflammatory bowel disease help heal the intestine
Wiley Although antiinflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis the mucosal lining of the intestine often remains ulcerated...
View ArticleCoherus BioSciences Inc CHRS Pharmaceuticals Healthcare Deals and Alliances...
SummaryCoherus BioSciences Inc Coherus BioSciences focuses on the development and commercialization of biosimilar drugs. Its pipeline portfolio includes candidates such as CHS1701 is a pegfilgrastim...
View ArticleStudy shows efficacy of biologics for mucosal healing in Crohn's disease and...
Although antiinflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis the mucosal lining of the intestine often remains ulcerated and...
View ArticleStickman and me
bmj;356mar225j1433FAF1faSpooky PookaA photograph representing the artists relationship with Crohns disease has won the 2017 Wellcome Image Award.StickmanThe Vicissitudes of Crohns by the...
View ArticleFirst patient dosed in extension study for Crohns disease therapy
RedHill Biopharma has announced dosing of the first patient in the openlabel extension study to the Phase III study with RHB104 for the treatment of Crohns disease.
View ArticleTiGenix to present at the dbVIC Deutsche Bank ADR Virtual Investor Conference...
Company invites individual and institutional investors as well as advisors to attend interactive realtime virtual event LEUVEN Belgium March 22 2017 PRNewswire TiGenix NV Euronext Brussels and Nasdaq...
View ArticleSigmoid Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySigmoid Pharma Ltd Sigmoid formerly Sigmoid Biotechnologies Ltd is a pharma company that develops therapies for unmet clinical needs in gastrointestinal and immunological diseases and disorders....
View ArticleTackling a Decade of Change
There has never been a more exciting time to be in the pharmaceutical industry if you like change that is. While change is a constant in business pharma has experienced unprecedented levels over the...
View ArticleImmunoproteomics Identifies New Biomarkers for Crohns Disease
Using a new screening approach a study aimed at developing a better blood test for Crohns disease CD successfully identified...
View ArticleEuropean Commission Approves AMGEVITA Biosimilar Adalimumab For The Treatment...
THOUSAND OAKS Calif. March 23 2017 PRNewswire Amgen NASDAQAMGN today announced that the European Commission EC has granted marketing authorization for AMGEVITA biosimilar adalimumab1 in all available...
View ArticleStudy of topdown infliximab use in children with Crohns disease
The Erasmus Medical Center in collaboration with the Netherlands Organisation for Health Research and Development and biosimilars maker Hospira now Pfizer is carrying out a study to investigate the...
View ArticleCROHN MICI La supriorit des traitements biologiques gurir la muqueuse...
Les traitements biologiques de la maladie inflammatoire chronique de l'intestin MICI contribuent à guérir l'intestin et ses muqueuses au contraire des traitements...
View ArticleHealth psychologists now treating functional heartburn Crohn's Disease IBS...
Health psychologists have begun treating gastrointestinal disorders that are strongly affected by stress including irritable bowel syndrome IBS Crohns disease functional heartburn functional dyspepsia...
View Article